Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 807 shares at $544.39 ($439K) on 2021-10-01, disclosed to the SEC on 2021-10-05.
Open-market sale of $439k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $538.02 | 47 | $25K | 5.8% |
| 2 | $539.10 | 6 | $3K | 0.7% |
| 3 | $540.93 | 88 | $48K | 10.9% |
| 4 | $543.15 | 126 | $68K | 15.6% |
| 5 | $543.15 | 126 | $68K | 15.6% |
| 6 | $544.39 | 181 |
| $99K |
| 22.5% |
| 7 | $544.39 | 181 | $99K | 22.5% |
| 8 | $547.06 | 51 | $28K | 6.4% |
| 9 | $551.58 | 1 | $552 | 0.1% |
| Total | $543.39 avg | 807 | $439K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |